Surmodics (SRDX)
(Delayed Data from NSDQ)
$41.95 USD
+0.01 (0.02%)
Updated Jun 20, 2024 04:00 PM ET
After-Market: $41.95 0.00 (0.00%) 7:12 PM ET
1-Strong Buy of 5 1
F Value F Growth B Momentum F VGM
Industry / Sector Report
Industry : Medical - Products
Zacks Industry Rank
Bottom 41% (148 out of 249)Zacks Sector Rank
Top 38% (6 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.50 | 1.69 | 9.99 |
Current Quarter Estimate | -0.31 | 5.88 | 57.00 |
Year Ago Quarter Estimate | 0.52 | 4.88 | 52.54 |
Next Quarter Estimate | -0.27 | 7.06 | 61.00 |
Next Year Estimate | 0.11 | 39.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -425.00 | 13.50 | 15.67 |
Next Year | 121.15 | 24.00 | 9.31 |
Last 5 Years | -22.90 | 3.90 | 8.10 |
Next 5 Years | NA | 11.90 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 37.45 | -13.85 |
Price/Book (MRQ) | 4.82 | 2.02 |
Price/Cash Flow (MRFY) | 53.49 | 11.68 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 9.44% | -10.60% |
Return on Equity (TTM) | 13.30% | -3.86% |
Debt to Equity (MRQ) | 0.24 | 20.61 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.